ArticlePloS one2026
Integrated in silico and in vivo larvicidal evaluation of compounds targeting juvenile hormone for malaria vector control.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Larvicidal Activity, GC-MS Profiling and Multitarget Molecular Docking of Essential Oils fromMolecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malaria remains a major global health challenge, particularly in sub-Saharan Africa, where it is a leading cause of morbidity and mortality. Inhibition of the mosquito juvenile hormone binding protein (MJHBP) is essential for developing selective and effective insecticides against malaria vectors. We performed virtual screening on 2,874 compounds from Agrochemical Insecticides Library using Python-based workflow in RDKit and Pandas libraries. The resultant compounds were subjected to molecular docking study against MJHBP (pdb:5V13). Further evaluation was performed through molecular mechanics generalized Born surface area (MM-GBSA) analysis, insecticide-likeness assessment, toxicity and environmental hazard predictions and Density Functional Theory (DFT) studies. The top-ranked compounds, together with the co-crystallized ligand, were subsequently subjected to molecular dynamics (MD) simulations. The molecular docking and MM-GBSA analyses identified fifteen lead compounds as potent inhibitors, exhibiting binding affinities ranging from -49.84 kcal/mol to -89.51 kcal/mol, values comparable to that of the co-crystallized ligand (-75.83 kcal/mol). The DFT results of the analysed compounds indicated that the top candidates, based on docking scores and binding energies, possessed lower HOMO-LUMO energy gap values, 1.52 eV for F3023-0929 and 2.36 eV for F2708-0061, compared to the co-crystallized ligand, which had a gap of 3.43 eV. All the top compounds displayed significant insecticidal potential with minimal environmental hazards. The stability of the most promising compounds (F2708-0061 and F3023-0929), identified based on binding free energy, was further corroborated through MD simulation. Further in vivo experiments revealed that F3023-0929 and F2708-0061 exhibited potent larvicidal activity, with LC₅₀ values of 37.75 ppm and 33.49 ppm, respectively, thereby supporting their potential as promising insecticidal candidates for mosquito control.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.